Axela

Toronto, Ontario - Canada

Axela provides researchers with a simple and effective approach to rapidly understand protein interactions and develop quantitative assays on a single platform. Real-time measurements provide more information from each sample.

Mission : Axela is delivering on its mission to provide researchers with simple and effective approaches to rapidly understand protein interactions and develop quantitative assays on a single platform.

Strategy : Axela's strategy is to provide effective research tools to unlock the potential of years of biomarker discovery. By offering a novel technology platform to both the research and future diagnostic markets Axela provides a unique opportunity to rapidly enable, advance and capture the value of novel discoveries.

Growing numbers of dotLab System users are enjoying the benefits of being able to use a single platform to directly understand protein interactions and develop superior quantitative assays. Researchers are adopting dotLab technology because it delivers:
* Real-time measurement of biomolecular complexes: Enabling research into disease management, previously impractical with conventional immunoassay methods
* Improved information content from a single sample: Speeding the transition from protein discovery to application
* Multiple analytical parameters from a single experiment: Enhancing the iterative scientific process
* Simple automated operation: Permitting full technical utilization with minimal training
* Affordable capital and operating costs: Save time and gain labor efficiencies.

Related
Axela
Canada

Manufacturer and supplier of instruments to assist in rapidly understanding protein interactions and developing quantitative assays on a single platform.